194 related articles for article (PubMed ID: 30252567)
21. NGS based identification of mutational hotspots for targeted therapy in anaplastic thyroid carcinoma.
Tiedje V; Ting S; Herold T; Synoracki S; Latteyer S; Moeller LC; Zwanziger D; Stuschke M; Fuehrer D; Schmid KW
Oncotarget; 2017 Jun; 8(26):42613-42620. PubMed ID: 28489587
[TBL] [Abstract][Full Text] [Related]
22. Long Non-coding RNA Expression in Anaplastic Thyroid Carcinomas.
Wang Y; Hardin H; Chu YH; Esbona K; Zhang R; Lloyd RV
Endocr Pathol; 2019 Dec; 30(4):262-269. PubMed ID: 31468286
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the Thyroid Cancer Genomic Landscape by Plasma-Based Circulating Tumor DNA Next-Generation Sequencing.
Tarasova VD; Tsai J; Masannat J; Hernandez Prera JC; Hallanger Johnson J; Veloski C; Agosto Salgado S; McIver B; Drusbosky LM; Chung CH
Thyroid; 2024 Feb; 34(2):197-205. PubMed ID: 37962267
[No Abstract] [Full Text] [Related]
24. Rare Manifestations of Anaplastic Thyroid Carcinoma: the Role of BRAF Mutation Analysis.
Song YS; Jung CK; Jung KC; Park YJ; Won JK
J Korean Med Sci; 2017 Oct; 32(10):1721-1726. PubMed ID: 28875621
[TBL] [Abstract][Full Text] [Related]
25. Primary high-grade non-anaplastic thyroid carcinoma: a retrospective study of 364 cases.
Xu B; David J; Dogan S; Landa I; Katabi N; Saliba M; Khimraj A; Sherman EJ; Tuttle RM; Tallini G; Ganly I; Fagin JA; Ghossein RA
Histopathology; 2022 Jan; 80(2):322-337. PubMed ID: 34449926
[TBL] [Abstract][Full Text] [Related]
26. Three-dimensional genome landscape comprehensively reveals patterns of spatial gene regulation in papillary and anaplastic thyroid cancers: a study using representative cell lines for each cancer type.
Zhang L; Xu M; Zhang W; Zhu C; Cui Z; Fu H; Ma Y; Huang S; Cui J; Liang S; Huang L; Wang H
Cell Mol Biol Lett; 2023 Jan; 28(1):1. PubMed ID: 36609218
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic Features of Mismatch Repair-Deficient Anaplastic Thyroid Carcinomas.
Wong KS; Lorch JH; Alexander EK; Nehs MA; Nowak JA; Hornick JL; Barletta JA
Thyroid; 2019 May; 29(5):666-673. PubMed ID: 30869569
[No Abstract] [Full Text] [Related]
28. Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer.
Yoo SK; Song YS; Lee EK; Hwang J; Kim HH; Jung G; Kim YA; Kim SJ; Cho SW; Won JK; Chung EJ; Shin JY; Lee KE; Kim JI; Park YJ; Seo JS
Nat Commun; 2019 Jun; 10(1):2764. PubMed ID: 31235699
[TBL] [Abstract][Full Text] [Related]
29. Early evolutionary divergence between papillary and anaplastic thyroid cancers.
Capdevila J; Mayor R; Mancuso FM; Iglesias C; Caratù G; Matos I; Zafón C; Hernando J; Petit A; Nuciforo P; Cameselle-Teijeiro JM; Álvarez C; Recio JA; Tabernero J; Matias-Guiu X; Vivancos A; Seoane J
Ann Oncol; 2018 Jun; 29(6):1454-1460. PubMed ID: 29648575
[TBL] [Abstract][Full Text] [Related]
30. Metastatic Anaplastic Thyroid Carcinoma in Complete Remission: Morphological, Molecular, and Clinical Work-Up of a Rare Case.
Stenman A; Hellgren LS; Jatta K; Hysek M; Zemmler M; Altena R; Nilsson IL; Bränström R; Zedenius J; Juhlin CC
Endocr Pathol; 2020 Mar; 31(1):77-83. PubMed ID: 32016808
[TBL] [Abstract][Full Text] [Related]
31. Response to RET-Specific Therapy in
Dias-Santagata D; Lennerz JK; Sadow PM; Frazier RP; Govinda Raju S; Henry D; Chung T; Kherani J; Rothenberg SM; Wirth LJ
Thyroid; 2020 Sep; 30(9):1384-1389. PubMed ID: 32292131
[No Abstract] [Full Text] [Related]
32. Clonal evolution analysis of paired anaplastic and well-differentiated thyroid carcinomas reveals shared common ancestor.
Dong W; Nicolson NG; Choi J; Barbieri AL; Kunstman JW; Abou Azar S; Knight J; Bilguvar K; Mane SM; Lifton RP; Korah R; Carling T
Genes Chromosomes Cancer; 2018 Dec; 57(12):645-652. PubMed ID: 30136351
[TBL] [Abstract][Full Text] [Related]
33. Next-generation sequencing in thyroid cancer.
Cha YJ; Koo JS
J Transl Med; 2016 Nov; 14(1):322. PubMed ID: 27871285
[TBL] [Abstract][Full Text] [Related]
34. Molecular Profile of Advanced Thyroid Carcinomas by Next-Generation Sequencing: Characterizing Tumors Beyond Diagnosis for Targeted Therapy.
Chen H; Luthra R; Routbort MJ; Patel KP; Cabanillas ME; Broaddus RR; Williams MD
Mol Cancer Ther; 2018 Jul; 17(7):1575-1584. PubMed ID: 29695638
[TBL] [Abstract][Full Text] [Related]
35. The mutation profile of differentiated thyroid cancer coexisting with undifferentiated anaplastic cancer resembles that of anaplastic thyroid cancer but not that of archetypal differentiated thyroid cancer.
Mika J; Łabaj W; Chekan M; Abramowicz A; Pietrowska M; Polański A; Widłak P
J Appl Genet; 2021 Feb; 62(1):115-120. PubMed ID: 33222100
[TBL] [Abstract][Full Text] [Related]
36. Novel Recurrent Altered Genes in Chinese Patients With Anaplastic Thyroid Cancer.
Zhang L; Ren Z; Su Z; Liu Y; Yang T; Cao M; Jiang Y; Tang Y; Chen H; Zhang W; Gong R; Wei T; Peng Y; Liu B; Zhang W; Yang L; Hu Y; Li Z; Zhu J; Xu H; Shu Y; Luo H
J Clin Endocrinol Metab; 2021 Mar; 106(4):988-998. PubMed ID: 33428730
[TBL] [Abstract][Full Text] [Related]
37. Recurrence and Survival After Gross Total Removal of Resectable Undifferentiated or Poorly Differentiated Thyroid Carcinoma.
Lee DY; Won JK; Choi HS; Park do J; Jung KC; Sung MW; Kim KH; Hah JH; Park YJ
Thyroid; 2016 Sep; 26(9):1259-68. PubMed ID: 27412715
[TBL] [Abstract][Full Text] [Related]
38. Anaplastic thyroid cancer: outcome and the mutation/expression profiles of potential targets.
Wu H; Sun Y; Ye H; Yang S; Lee SL; de las Morenas A
Pathol Oncol Res; 2015 Jul; 21(3):695-701. PubMed ID: 25588542
[TBL] [Abstract][Full Text] [Related]
39. Establishment and characterization of a new patient-derived anaplastic thyroid cancer cell line (C3948), obtained through fine-needle aspiration cytology.
Pinto AT; Pojo M; Simões-Pereira J; Roque R; Saramago A; Roque L; Martins C; André S; Cabeçadas J; Leite V; Cavaco BM
Endocrine; 2019 Nov; 66(2):288-300. PubMed ID: 31368081
[TBL] [Abstract][Full Text] [Related]
40. The genomic and evolutionary landscapes of anaplastic thyroid carcinoma.
Zeng PYF; Prokopec SD; Lai SY; Pinto N; Chan-Seng-Yue MA; Clifton-Bligh R; Williams MD; Howlett CJ; Plantinga P; Cecchini MJ; Lam AK; Siddiqui I; Wang J; Sun RX; Watson JD; Korah R; Carling T; Agrawal N; Cipriani N; Ball D; Nelkin B; Rooper LM; Bishop JA; Garnis C; Berean K; Nicolson NG; Weinberger P; Henderson YC; Lalansingh CM; Tian M; Yamaguchi TN; Livingstone J; Salcedo A; Patel K; Vizeacoumar F; Datti A; Xi L; Nikiforov YE; Smallridge R; Copland JA; Marlow LA; Hyrcza MD; Delbridge L; Sidhu S; Sywak M; Robinson B; Fung K; Ghasemi F; Kwan K; MacNeil SD; Mendez A; Palma DA; Khan MI; Shaikh M; Ruicci KM; Wehrli B; Winquist E; Yoo J; Mymryk JS; Rocco JW; Wheeler D; Scherer S; Giordano TJ; Barrett JW; Faquin WC; Gill AJ; Clayman G; Boutros PC; Nichols AC
Cell Rep; 2024 Mar; 43(3):113826. PubMed ID: 38412093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]